How do analysts rate AbbVie (abbv) stock?

Within the last quarter, AbbVie (NYSE: ABBV) has observed the following analyst ratings: According to 8 analyst offering 12-month price targets in the last 3 months, AbbVie has an average price target of $169.38 with a high of $200.00 and a low of $140.00. Below is a summary of how these 8 analysts rated AbbVie over the past 3 months.

Should you buy AbbVie (abbv) stock?

According to the issued ratings of 13 analysts in the last year, the consensus rating for AbbVie stock is Moderate Buy based on the current 3 hold ratings and 10 buy ratings for ABBV. The average twelve-month price prediction for AbbVie is $177.43 with a high price target of $196.00 and a low price target of $150.00.

What are abbv share price targets?

Their ABBV share price targets range from $150.00 to $196.00. On average, they anticipate the company's stock price to reach $174.31 in the next year. This suggests a possible upside of 7.9% from the stock's current price. View analysts price targets for ABBV or view top-rated stocks among Wall Street analysts.